Leucine-rich repeat-containing protein 59 mediates nuclear import of cancerous inhibitor of PP2A in prostate cancer cells
出版年份 2015 全文链接
标题
Leucine-rich repeat-containing protein 59 mediates nuclear import of cancerous inhibitor of PP2A in prostate cancer cells
作者
关键词
CIP2A, LRRC59, PP2A, Prostate cancer, Biomarker
出版物
TUMOR BIOLOGY
Volume 36, Issue 8, Pages 6383-6390
出版商
Springer Nature
发表日期
2015-04-03
DOI
10.1007/s13277-015-3326-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancerous inhibitor of protein phosphatase 2A promotes premature chromosome segregation and aneuploidy in prostate cancer cells through association with shugoshin
- (2015) Rajash Pallai et al. TUMOR BIOLOGY
- Cellular localization of CIP2A determines its prognostic impact in superficial spreading and nodular melanoma
- (2015) Vivi Ann Flørenes et al. Cancer Medicine
- Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): an oncoprotein with many hands
- (2015) Pradip De et al. Oncotarget
- Circumventing Cellular Control of PP2A by Methylation Promotes Transformation in an Akt-Dependent Manner
- (2015) Jennifer B. Jackson et al. NEOPLASIA
- Novel Fusion Transcripts Associate with Progressive Prostate Cancer
- (2014) Yan P. Yu et al. AMERICAN JOURNAL OF PATHOLOGY
- PME-1 Modulates Protein Phosphatase 2A Activity to Promote the Malignant Phenotype of Endometrial Cancer Cells
- (2014) E. Wandzioch et al. CANCER RESEARCH
- Antagonism of SET Using OP449 Enhances the Efficacy of Tyrosine Kinase Inhibitors and Overcomes Drug Resistance in Myeloid Leukemia
- (2014) A. Agarwal et al. CLINICAL CANCER RESEARCH
- CIP2A is overexpressed and involved in the pathogenesis of chronic myelocytic leukemia by interacting with breakpoint cluster region-Abelson leukemia virus
- (2014) Juandong Wang et al. MEDICAL ONCOLOGY
- PP2A Inhibition Is a Common Event in Colorectal Cancer and Its Restoration Using FTY720 Shows Promising Therapeutic Potential
- (2014) I. Cristobal et al. MOLECULAR CANCER THERAPEUTICS
- Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer
- (2014) M. Janghorban et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2A
- (2014) H-C Yu et al. Cell Death & Disease
- CIP2A Modulates Cell-Cycle Progression in Human Cancer Cells by Regulating the Stability and Activity of Plk1
- (2013) J.-S. Kim et al. CANCER RESEARCH
- Chk1 Targeting Reactivates PP2A Tumor Suppressor Activity in Cancer Cells
- (2013) A. Khanna et al. CANCER RESEARCH
- Increased expression of CIP2A in aggressive subtypes of B-cell lymphoma
- (2013) Laura Lilja et al. HISTOPATHOLOGY
- Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) Protein Is Involved in Centrosome Separation through the Regulation of NIMA (Never In Mitosis Gene A)-related Kinase 2 (NEK2) Protein Activity
- (2013) Ae Lee Jeong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CIP2A expression and prognostic role in patients with esophageal adenocarcinoma
- (2013) Tuomo Rantanen et al. MEDICAL ONCOLOGY
- Clinical implications of CIP2A protein expression in breast cancer
- (2013) Guangzhe Yu et al. MEDICAL ONCOLOGY
- Cancerous Inhibitor of Protein Phosphatase 2A Mediates Bortezomib-Induced Autophagy in Hepatocellular Carcinoma Independent of Proteasome
- (2013) Hui-Chuan Yu et al. PLoS One
- CIP2A facilitates apoptotic resistance of fibroblast-like synoviocytes in rheumatoid arthritis independent of c-Myc expression
- (2013) Jaejoon Lee et al. RHEUMATOLOGY INTERNATIONAL
- CIP2A expression is associated with altered expression of epithelial–mesenchymal transition markers and predictive of poor prognosis in pancreatic ductal adenocarcinoma
- (2013) Lei Wang et al. TUMOR BIOLOGY
- Inhibition of CIP2A determines erlotinib-induced apoptosis in hepatocellular carcinoma
- (2012) Hui-Chuan Yu et al. BIOCHEMICAL PHARMACOLOGY
- CIP2A overexpression is associated with c-Myc expression in colorectal cancer
- (2012) Camilla Böckelman et al. CANCER BIOLOGY & THERAPY
- HEAT Repeat 1 Motif Is Required for B56γ-containing Protein Phosphatase 2A (B56γ-PP2A) Holoenzyme Assembly and Tumor-suppressive Function
- (2012) Yumiko Nobumori et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CIP2A Is a Predictor of Poor Prognosis in Colon Cancer
- (2012) Hao-Wei Teng et al. JOURNAL OF GASTROINTESTINAL SURGERY
- CIP2A-mediated Akt activation plays a role in bortezomib-induced apoptosis in head and neck squamous cell carcinoma cells
- (2012) Yu-Chin Lin et al. ORAL ONCOLOGY
- CIP2A Promotes Proliferation of Spermatogonial Progenitor Cells and Spermatogenesis in Mice
- (2012) Sami Ventelä et al. PLoS One
- Nuclear Import of Exogenous FGF1 Requires the ER-Protein LRRC59 and the Importins Kpnα1 and Kpnβ1
- (2012) Yan Zhen et al. TRAFFIC
- CIP2A is overexpressed in human ovarian cancer and regulates cell proliferation and apoptosis
- (2012) Yuanyuan Fang et al. TUMOR BIOLOGY
- CIP2A protein expression in high-grade, high-stage bladder cancer
- (2012) Lisa P. Huang et al. Cancer Medicine
- Prognostic role of CIP2A expression in serous ovarian cancer
- (2011) C Böckelman et al. BRITISH JOURNAL OF CANCER
- Clk2 and B56β Mediate Insulin-Regulated Assembly of the PP2A Phosphatase Holoenzyme Complex on Akt
- (2011) Joseph T. Rodgers et al. MOLECULAR CELL
- ATM-mediated phosphorylation activates the tumor-suppressive function of B56γ–PP2A
- (2011) G P Shouse et al. ONCOGENE
- ETS1 Mediates MEK1/2-Dependent Overexpression of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) in Human Cancer Cells
- (2011) Anchit Khanna et al. PLoS One
- CIP2A expression and localization in oral carcinoma and dysplasia
- (2010) Joseph Katz et al. CANCER BIOLOGY & THERAPY
- Identification of PP2A Complexes and Pathways Involved in Cell Transformation
- (2010) A. A. Sablina et al. CANCER RESEARCH
- Mechanisms of MYC stabilization in human malignancies
- (2010) Melissa R. Junttila et al. CELL CYCLE
- Small-molecule protein-protein interaction inhibitors: Therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations
- (2010) Peter Buchwald IUBMB LIFE
- B55α PP2A Holoenzymes Modulate the Phosphorylation Status of the Retinoblastoma-related Protein p107 and Its Activation
- (2010) Girish Jayadeva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CIP2A expression is increased in prostate cancer
- (2010) Markku H Vaarala et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells
- (2010) K-F Chen et al. ONCOGENE
- PME-1 Protects Extracellular Signal-Regulated Kinase Pathway Activity from Protein Phosphatase 2A-Mediated Inactivation in Human Malignant Glioma
- (2009) P. Puustinen et al. CANCER RESEARCH
- CIP2A Is Associated with Human Breast Cancer Aggressivity
- (2009) C. Come et al. CLINICAL CANCER RESEARCH
- Multiple pathways regulated by the tumor suppressor PP2A in transformation
- (2008) Jukka Westermarck et al. TRENDS IN MOLECULAR MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now